Anvisa Determines Seizure of Falsified Lots of Moungharo
6 Articles
6 Articles
CartaCapital
Correio BrazilienseAgency also prohibits sale of products without registration
The National Agency for Health Surveillance (Anvisa) determined, on Friday, the seizure of falsified lots of the medicine Mounjaro, indicated for the treatment of type 2 diabetes and obesity. Understand the case: Man receives 54 doses of anti-ophidic serum after crushing of rattlesnake and exhausts hospital stocks in the USA Consuming oats every day is enough? Guide draws main doubts about the fibers Pharmaceuticals Eli Lilly, manufacturer respo…
The National Agency for Health Surveillance (Anvisa) determined, on Friday (10/7), the seizure of counterfeit lots of the medicine Mounjaro. The measure was taken after the holder of the registration of the medicine identify on the market units with divergent characteristics of the originals. According to the resolution published by the agency, the following lots cannot be marketed, distributed or used: Mounjaro 10 mg: lot 855044 Mounjaro 15 mg:…
Agency identified incompatible numbering and manufacture by unauthorized companies, prohibiting sale and use of the medicinal product
The National Agency for Health Surveillance (Anvisa) determined, on Friday, 10, the seizure of falsified lots of Mounjaro, a medicine used in the treatment of type 2 diabetes and obesity.The measure was taken after the manufacturer Eli Lilly identified products in circulation with characteristics different from those of the original medicine.The falsified lots cannot be marketed, distributed or used.The identified lots are:Mounjaro 10 mg: lot 85…
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
